Dendritic cell control of immune responses by Penelope Anne Morel, Lisa H Butterfield

Get full text

Dendritic Cell-Based Vaccines Positively Impact Natural Killer and Regulatory T Cells in Hepatocellular Carcinoma Patients by Sarah M. Bray, Lazar Vujanovic, Lisa H. Butterfield

Get full text

Improving the therapeutic index in adoptive cell therapy: key factors that impact efficacy by Francesco Marincola, Ena Wang, Lisa H Butterfield, Alessandra Cesano

Get full text

CD56dim CD16− Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α by Lazar Vujanovic, Lazar Vujanovic, Christopher Chuckran, Yan Lin, Yan Lin, Fei Ding, Fei Ding, Cindy A. Sander, Cindy A. Sander, Patricia M. Santos, Patricia M. Santos, Joel Lohr, Afshin Mashadi-Hossein, Sarah Warren, Andy White, Alan Huang, John M. Kirkwood, John M. Kirkwood, Lisa H. Butterfield, Lisa H. Butterfield, Lisa H. Butterfield, Lisa H. Butterfield

Get full text

Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016 by James L. Gulley, Elizabeth A. Repasky, Laura S. Wood, Lisa H. Butterfield

Get full text

Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al by Lisa H Butterfield, Hideho Okada, Sabine Mueller, Zinal S Chheda, Bindu Hegde, Akane Yamamichi

Get full text

Cancer immunotherapy trials: leading a paradigm shift in drug development by Leisha A Emens, F. Stephen Hodi, Lisa H. Butterfield, Howard L. Kaufman, Francesco M. Marincola

Get full text

Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab by Yan Lin, Lisa H. Butterfield, Ahmad A. Tarhini, Janet Retseck, Robert VanderWeele, Hui-Min Lin

Get full text

Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma by Janet Retseck, Alexis Nasr, Yan Lin, Huang Lin, Prateek Mendiratta, Lisa H. Butterfield, Ahmad A. Tarhini

Get full text

Prospective clinical testing of regulatory dendritic cells (DCreg) in organ transplantation by ANGUS W THOMSON, ALAN F ZAHORCHAK, Mohamed B. Ezzelarab, Lisa H. Butterfield, Fadi G. Lakkis, Diana M Metes

Get full text

Immuno-metabolic dendritic cell vaccine signatures associate with overall survival in vaccinated melanoma patients by Juraj Adamik, Paul V. Munson, Deena M. Maurer, Felix J. Hartmann, Sean C. Bendall, Rafael J. Argüello, Lisa H. Butterfield

Get full text

The future of cancer immunotherapy for brain tumors: a collaborative workshop by Christine E. Brown, Samantha Bucktrout, Lisa H. Butterfield, Olga Futer, Evanthia Galanis, Adilia Hormigo, Michael Lim, Hideho Okada, Robert Prins, Sara Siebel Marr, Kirk Tanner

Get full text

Distinct metabolic states guide maturation of inflammatory and tolerogenic dendritic cells by Juraj Adamik, Paul V. Munson, Felix J. Hartmann, Alexis J. Combes, Philippe Pierre, Matthew F. Krummel, Sean C. Bendall, Rafael J. Argüello, Lisa H. Butterfield

Get full text

The great debate at “Immunotherapy Bridge 2018”, Naples, November 29th, 2018 by Paolo A. Ascierto, Lisa H. Butterfield, Sandra Demaria, Robert L. Ferris, Gordon J. Freeman, Roger S. Lo, Alberto Mantovani, Paul Nathan, Omid Hamid, Katerina Politi, Igor Puzanov

Get full text

Interleukin 32 expression in human melanoma by Helicia Paz, Jennifer Tsoi, Anusha Kalbasi, Catherine S. Grasso, William H. McBride, Dörthe Schaue, Lisa H. Butterfield, Deena M. Maurer, Antoni Ribas, Thomas G. Graeber, James S. Economou

Get full text

SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art by Lisa H. Butterfield, Mary L. Disis, Bernard A. Fox, David R. Kaufman, Samir N. Khleif, Ena Wang, on behalf of the Society for Immunotherapy of Cancer Immuno-Oncology Biomarkers: State of the Art workshop speakers

Get full text

The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021 by Paolo A. Ascierto, Lisa H. Butterfield, Olivera J. Finn, Andrew Futreal, Omid Hamid, Theresa LaVallee, Michael A. Postow, Igor Puzanov, Jeffrey Sosman, Bernard A. Fox, Patrick Hwu

Get full text

Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR by Theresa L Walunas, Lisa H Butterfield, William J Murphy, Elizabeth M Jaffee, Bart O Roep, Nicholas L Bayless, Jeffrey A Bluestone, Samantha Bucktrout, Christian A Koch, Arlene H Sharpe

Get full text

Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab. by Ahmad A Tarhini, Howard Edington, Lisa H Butterfield, Yan Lin, Yongli Shuai, Hussein Tawbi, Cindy Sander, Yan Yin, Matthew Holtzman, Jonas Johnson, Uma N M Rao, John M Kirkwood

Get full text

Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common rule by Jerome Galon, Sandra Demaria, Lisa H. Butterfield, Robert L. Ferris, Howard L. Kaufman, Willem W. Overwijk, Francesco M. Marincola, Pamela S. Ohashi, Ira Mellman, Pierre G. Coulie, Samir N. Khleif, Suzanne L. Topalian

Get full text